Bristol-Myers Squibb Company (NYSE:BMY) Q4 2023 Earnings Call Transcript February 2, 2024 Bristol-Myers Squibb Company isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Bristol-Myers Squibb Fourth Quarter 2023 Earnings Conference Call. All participants will be in listen-only […]
Related Keywords
Japan , , Chronic Lymphocytic Leukemia , Mantle Cell Lymphoma , Massive Vote , Approval From Wall Street Analysts , Bristol Myers Squibb Company , Fourth Quarter , David Elkins , Jim Power , Forward Looking Statement , Chris Boerner ,
comparemela.com © 2020. All Rights Reserved.